BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Kineta Inc. 

307 Westlake Ave North
Suite 200
Seattle  Washington  98109  U.S.A.
Phone: 206-378-0400 Fax: 206-378-0408


SEARCH JOBS




Industry
Biotechnology

Segment
Start Up





 Company News
Its First Drug In Clinic, Kineta Inc. Keeps Raising Cash From Odd Sources 6/5/2014 7:56:44 AM
Kineta Inc. And RLB Holdings Announce New Joint Venture To Address High-Need Therapeutics Including Autoimmune Diseases 4/15/2014 9:26:47 AM
Kineta Inc. Announces Enrollment Of First Subject In 1B Clinical Trial 11/26/2013 9:25:21 AM
RLB Holdings and Kineta Inc. Announce Second Investment 2/6/2013 2:02:53 PM
Kineta Inc. Adds to Its Pipeline of Venom-Derived Drug Candidates, In-licenses Conotoxin Program for Non-Narcotic Pain Relief 1/25/2013 9:31:55 AM
Kineta Inc. Announces Regulatory Clearance to Initiate a Phase 1 Clinical Trial for ShK-186 8/21/2012 9:34:38 AM
Kineta Inc. Pulls in $5.8 Million for Autoimmune Drug 8/14/2012 7:17:20 AM
University of Washington, University of Texas Medical School Branch and Kineta Inc. Granted $8.1 Million for Biodefense Antiviral Drug Development 5/8/2012 9:58:18 AM
Kineta Inc. Programs Named "Top Projects" Second Year Running 11/30/2011 9:02:31 AM
New Funding for Kineta Inc.'s Novel Antiviral Program Targeting the Spectrum of Global Diseases 8/12/2011 10:41:39 AM
12